EA001376B1 - Новые производные эритромицина, способ их получения и их применение в качестве медикаментов - Google Patents

Новые производные эритромицина, способ их получения и их применение в качестве медикаментов Download PDF

Info

Publication number
EA001376B1
EA001376B1 EA199800768A EA199800768A EA001376B1 EA 001376 B1 EA001376 B1 EA 001376B1 EA 199800768 A EA199800768 A EA 199800768A EA 199800768 A EA199800768 A EA 199800768A EA 001376 B1 EA001376 B1 EA 001376B1
Authority
EA
Eurasian Patent Office
Prior art keywords
formula
compounds
methyl
radical
dideoxy
Prior art date
Application number
EA199800768A
Other languages
English (en)
Russian (ru)
Other versions
EA199800768A1 (ru
Inventor
Константэн Агуридас
Жан-Франсуа Шанто
Original Assignee
Хехст Марион Руссель
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хехст Марион Руссель filed Critical Хехст Марион Руссель
Publication of EA199800768A1 publication Critical patent/EA199800768A1/ru
Publication of EA001376B1 publication Critical patent/EA001376B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
EA199800768A 1996-02-28 1997-02-27 Новые производные эритромицина, способ их получения и их применение в качестве медикаментов EA001376B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602472A FR2745290B1 (fr) 1996-02-28 1996-02-28 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
PCT/FR1997/000351 WO1997031929A1 (fr) 1996-02-28 1997-02-27 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
EA199800768A1 EA199800768A1 (ru) 1999-02-25
EA001376B1 true EA001376B1 (ru) 2001-02-26

Family

ID=9489659

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800768A EA001376B1 (ru) 1996-02-28 1997-02-27 Новые производные эритромицина, способ их получения и их применение в качестве медикаментов

Country Status (31)

Country Link
US (1) US6096714A (OSRAM)
EP (1) EP0885234B1 (OSRAM)
JP (1) JP4102440B2 (OSRAM)
KR (1) KR100486053B1 (OSRAM)
CN (1) CN1168734C (OSRAM)
AP (1) AP952A (OSRAM)
AR (1) AR005999A1 (OSRAM)
AT (1) ATE217633T1 (OSRAM)
AU (1) AU716204B2 (OSRAM)
BG (1) BG63207B1 (OSRAM)
BR (1) BR9707709B1 (OSRAM)
CZ (1) CZ293893B6 (OSRAM)
DE (1) DE69712610T2 (OSRAM)
DK (1) DK0885234T3 (OSRAM)
EA (1) EA001376B1 (OSRAM)
EE (1) EE9800265A (OSRAM)
ES (1) ES2176698T3 (OSRAM)
FR (1) FR2745290B1 (OSRAM)
HU (1) HU227567B1 (OSRAM)
IL (1) IL125622A (OSRAM)
NO (1) NO983955L (OSRAM)
NZ (1) NZ331600A (OSRAM)
OA (1) OA10845A (OSRAM)
PL (1) PL191736B1 (OSRAM)
PT (1) PT885234E (OSRAM)
SK (1) SK118498A3 (OSRAM)
TR (1) TR199801713T2 (OSRAM)
UA (1) UA58504C2 (OSRAM)
WO (1) WO1997031929A1 (OSRAM)
YU (1) YU37098A (OSRAM)
ZA (1) ZA971659B (OSRAM)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999021870A1 (en) * 1997-10-29 1999-05-06 Taisho Pharmaceutical Co., Ltd. Erythromycin a 11, 12-carbamate derivatives
AU9649598A (en) * 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a, 11,12-carbamate derivatives
FR2792637B1 (fr) * 1999-04-26 2001-06-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2780977B1 (fr) * 1998-07-09 2000-09-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2781484B1 (fr) * 1998-07-21 2001-08-10 Hoechst Marion Roussel Inc Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
IL144178A0 (en) 1999-01-27 2002-05-23 Pfizer Prod Inc Ketolide antibiotics
OA11945A (en) * 1999-05-24 2006-04-13 Pfizer Prod Inc 13-Methyl erythromycin derivatives.
AU6316400A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
AU6183800A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
WO2001010878A1 (fr) * 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
EP1638549A4 (en) 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007069264A2 (en) * 2005-12-15 2007-06-21 Alembic Limited Reference standards for determining the purity of telithromycin and processes therefor
CA2703475A1 (en) * 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
EP2358379B1 (en) * 2008-10-24 2015-12-16 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
MX361413B (es) 2010-03-22 2018-12-05 Cempra Pharmaceuticals Inc Star Formas cristalinas de un macrólido y usos para las mismas.
KR101945324B1 (ko) 2010-05-20 2019-02-07 셈프라 파마슈티컬스, 인크. 매크로라이드들 및 케톨라이드들과 이의 중간체들을 제조하는 공정들
US9815863B2 (en) 2010-09-10 2017-11-14 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
KR20140139083A (ko) 2012-03-27 2014-12-04 셈프라 파마슈티컬스, 인크. 마크롤라이드계 항생제를 투여하기 위한 비경구 제제
RU2015138796A (ru) 2013-03-14 2017-04-19 Семпра Фармасьютикалс, Инк. Способы и составы для лечения респираторных заболеваний
JP6675973B2 (ja) 2013-03-15 2020-04-08 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライド抗菌薬を調製するための集束的な方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US487411A (en) * 1892-12-06 Island
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5444031A (en) * 1993-01-21 1995-08-22 Calgon Carbon Corporation Process for making catalytic carbon
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
ATE217633T1 (de) 2002-06-15
JP4102440B2 (ja) 2008-06-18
PL328608A1 (en) 1999-02-01
DK0885234T3 (da) 2002-08-26
AR005999A1 (es) 1999-07-21
OA10845A (fr) 2003-02-05
CN1212700A (zh) 1999-03-31
DE69712610D1 (de) 2002-06-20
PL191736B1 (pl) 2006-06-30
BG63207B1 (bg) 2001-06-29
SK118498A3 (en) 1999-07-12
CZ293893B6 (cs) 2004-08-18
EA199800768A1 (ru) 1999-02-25
HUP9902576A3 (en) 2001-03-28
YU37098A (sh) 1999-07-28
AP952A (en) 2001-03-29
NZ331600A (en) 1999-08-30
ES2176698T3 (es) 2002-12-01
FR2745290B1 (fr) 1998-04-03
AP9801318A0 (en) 1998-09-30
UA58504C2 (uk) 2003-08-15
JP2000505469A (ja) 2000-05-09
PT885234E (pt) 2002-10-31
WO1997031929A1 (fr) 1997-09-04
BG102691A (en) 1999-06-30
NO983955D0 (no) 1998-08-27
HU227567B1 (en) 2011-08-29
FR2745290A1 (fr) 1997-08-29
TR199801713T2 (xx) 1998-12-21
BR9707709B1 (pt) 2014-10-14
KR100486053B1 (ko) 2005-06-16
EE9800265A (et) 1999-02-15
US6096714A (en) 2000-08-01
CZ258798A3 (cs) 1998-12-16
ZA971659B (en) 1998-02-26
NO983955L (no) 1998-08-27
DE69712610T2 (de) 2002-11-28
EP0885234A1 (fr) 1998-12-23
AU1929897A (en) 1997-09-16
HUP9902576A1 (hu) 1999-12-28
EP0885234B1 (fr) 2002-05-15
CN1168734C (zh) 2004-09-29
BR9707709A (pt) 1999-04-06
AU716204B2 (en) 2000-02-24
IL125622A (en) 2003-10-31
IL125622A0 (en) 1999-04-11
KR19990087324A (ko) 1999-12-27

Similar Documents

Publication Publication Date Title
EA001376B1 (ru) Новые производные эритромицина, способ их получения и их применение в качестве медикаментов
JP3140703B2 (ja) 新規なエリスロマイシン、それらの製造法及び薬剤としての用途
JP3334980B2 (ja) 新規なエリスロマイシン誘導体、それらの製造法及びそれらの薬剤としての用途
CA2055912C (fr) Nouveaux derives de l'erythromycine, leur procede de preparation, les nouveaux intermediaires obtenus et leur application comme medicaments
RU2126416C1 (ru) Производные эритромицина, фармацевтическая композиция на их основе, способ их получения и промежуточные соединения
KR100371473B1 (ko) 신규한에리스로마이신유도체,그의제조방법및의약으로서의용도
JP4573925B2 (ja) 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
CA2282666C (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EA002168B1 (ru) Новые производные эритромицина, способ их получения и их применение в качестве медикаментов
EP1189913B1 (en) Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition
EA001733B1 (ru) Производные эритромицина, способ их получения и применение
RU2144541C1 (ru) Производные эритромицина, способ их получения, промежуточный продукт, фармацевтическая композиция
USRE38520E1 (en) Erythromycin derivatives, method for preparing same, and use thereof as drugs
AU761551B2 (en) Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines
KR20000062286A (ko) 신규한 에리트로마이신 유도체, 제조 방법 및 의약품으로서 용도
CA2247175C (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
JPS6121238B2 (OSRAM)
FR2614894A1 (fr) Nouvelles oximes derivees de la tylosine, leur procede de preparation et les compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
MK4A Patent expired

Designated state(s): RU